Skip to content

Clinical trials

Suspended Glioblastoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioblastoma Status: Suspended Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20131
20171
20201
20234
20246
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Suspended16

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Case Comprehensive Cancer Center2
Duke University2
Northwell Health2
Cortice Biosciences, Inc.1
Emory University1
InSightec1
National Cancer Institute (NCI)1
NaviFUS Corporation1
OncoHost Ltd.1
Petrov, Andrey1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioblastoma16
Glioma6
Astrocytoma3
Brain Neoplasms3
Gliosarcoma2
Neoplasms2
Central Nervous System Neoplasms1
Neoplasms, Nerve Tissue1
Oligodendroglioma1
Seizures1

Trials

Showing 26 to 16 of 16. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.